Avrobio | Fremdkapital

Loan Capital Veränderung Datum
Adcock Ingram Holdings ZAR 279.98M 17.16M 2023-06
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Celltrion KRW 107.12B 12.27B 2023-12
Cspc Pharmaceutical CNY 107.06M 99.73M 2023-12
Ecofibre AUD 25.7M 221K 2023-06
Gilead Sciences USD 23.19B 1.98B 2023-09
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Kangmei Pharma CNY 195.86M 3.82M 2023-09
Knight Therapeutics CAD 54.49M 1.67M 2023-09
Laboratorios Farma EUR 54.54M 4.9M 2023-06
MacroGenics USD 0 0 2022-06
Magenta Therapeutics USD 0 0 2022-06
Malin Corporation EUR 0 0 2021-12
Medical Developments International AUD 2.21M 141K 2023-06
Neuren Pharmaceuticals AUD 0 0 2021-12
Organigram Holdings CAD 100K 18K 2023-03
Pfizer USD 61.05B 308M 2023-09
Pharma Mar EUR 28.82M 234K 2023-09
Probiotec AUD 35.33M 1.42M 2023-06
Qiagen NV USD 1.38B 5.58M 2023-09
Roche Holding CHF 20.35B 1.05B 2023-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Sartorius EUR 5.04B 2.76B 2023-09
Sino Biopharmaceutical CNY 1.03B 3.23B 2023-06
Takeda JPY 4.4T 74.11B 2023-09
Zz Pientze Pharmaceu 126.63M 8.63M 2023-09



Avrobio Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.